Rosalind, Geninus expand single-cell analysis offerings in Asia

By The Science Advisory Board staff writers

April 15, 2021 -- Rosalind has partnered with Geninus and HeLiXrUs to enable a new single-cell data analysis solution for cancer researchers in Asia.

Rosalind will combine its platform with Geninus' Celinus single-cell RNA sequencing services to provide expanded analysis and interpretation of data, as well as sharing and collaboration across labs and geographies. The integrated analysis offering is now available to clinicians, academic researchers, and pharmaceutical companies in South Korea and other Asian markets.

Celinus allows direct measurement of gene expression and genetic alteration with single-cell resolution to quantify intracellular heterogeneity and characterize cell types, states, and cellular transition dynamics. It can support single-cell gene expression, single-cell immune profiling, single-nucleus gene expression, single-cell multiome ATAC, and spatial gene expression from the 10X Genomics platform.

HeLiXrUs is a channel partnership company formed to help establish the relationship between Rosalind and Geninus.

Rosalind launches web-based SARS-CoV-2 variant tracker
Rosalind has launched a web-based platform called Rosalind Diagnostic Monitoring for tracking SARS-CoV-2 variants and evaluating their effects on diagnostic...

Copyright © 2021

International Society for Cell and Gene Therapy Annual Meeting
May 4 - June 7
San Francisco, California United States
Interphex 2022 Conference
May 24-26
New York, New York United States
American Society for Mass Spectrometry Annual Conference
June 5-9
Minneapolis, Minnesota United States
American Society for Microbiology Microbe Meeting
June 9-13
District of Columbia United States
HPLC 2022
June 18-23
San Diego, California United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter